MA
TMO icon

MCF Advisors’s Thermo Fisher Scientific TMO Stock Holding History

MCF Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4M Buy
7,978
+807
+11% +$387K 0.14% 88
2026
Q1 		$3.53M Buy
7,171
+1,967
+38% +$1.07M 0.15% 75
2025
Q4 		$3.02M Buy
5,204
+2,123
+69% +$1.2M 0.17% 65
2025
Q3 		$1.5M Buy
3,081
+1,794
+139% +$835K 0.09% 78
2025
Q2 		$522K Sell
1,287
-2,113
-62% -$883K 0.03% 147
2025
Q1 		$1.69M Sell
3,400
-115
-3% -$62.3K 0.12% 58
2024
Q4 		$1.83M Buy
3,515
+560
+19% +$308K 0.13% 57
2024
Q3 		$1.83M Buy
2,955
+37
+1% +$21.9K 0.13% 57
2024
Q2 		$1.61M Sell
2,918
-58
-2% -$33.2K 0.12% 58
2024
Q1 		$1.73M Sell
2,976
-17
-0.6% -$9.54K 0.13% 55
2023
Q4 		$1.59M Buy
2,993
+1,176
+65% +$569K 0.13% 55
2023
Q3 		$920K Buy
1,817
+679
+60% +$362K 0.08% 81
2023
Q2 		$594K Sell
1,138
-1,310
-54% -$707K 0.05% 109
2023
Q1 		$1.41M Sell
2,448
-9
-0.4% -$5.07K 0.13% 51
2022
Q4 		$1.35M Buy
2,457
+541
+28% +$287K 0.14% 50
2022
Q3 		$972K Buy
1,916
+811
+73% +$454K 0.11% 67
2022
Q2 		$601K Sell
1,105
-43
-4% -$23.7K 0.06% 81
2022
Q1 		$678K Buy
+1,148
New +$659K 0.06% 92
2021
Q4 		– Sell
-750
Closed -$429K – 620
2021
Q3 		$429K Buy
750
+257
+52% +$141K 0.04% 114
2021
Q2 		$249K Buy
493
+154
+45% +$72.7K 0.03% 153
2021
Q1 		$155K Buy
+339
New +$162K 0.02% 185
2015
Q2 		– Sell
-83
Closed -$11K – 450
2015
Q1 		$11K Hold
83
– – ﹤0.01% 319
2014
Q4 		$10K Hold
83
– – ﹤0.01% 310
2014
Q3 		$10K Buy
+83
New +$10.1K ﹤0.01% 320

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

MCF Advisors's TMO Position: Q2 2026 in Review

MCF Advisors increased its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, buying an estimated $387K and bringing the position to 7,978 shares worth $4M. The position accounts for 0.14% of the portfolio, ranked #88.

MCF Advisors first reported a position in TMO in Q3 2014 and has held it in 24 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • MCF Advisors held 7,978 shares of Thermo Fisher Scientific worth $4M as of Q2 2026.
  • MCF Advisors bought 807 Thermo Fisher Scientific shares in Q2 2026, an estimated $387K.
  • Thermo Fisher Scientific made up 0.14% of MCF Advisors's portfolio in Q2 2026, its #88 holding.
  • MCF Advisors first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 24 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.